Affymax   Report issue

Contributed to NME For profit Phase 3
Founded: Palo Alto CA United States (1988)
Status: Acquired by Glaxo (1995) → now GlaxoSmithKline (2000)

Organization Overview

First Clinical Trial
2004
NCT00097747
First Marketed Drug
2012
peginesatide (omontys)
First NDA Approval
2012
peginesatide (omontys)
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Affymax, Inc